MARKET

TVGNW

TVGNW

Tevogen Bio
NASDAQ
0.0429
+0.0006
+1.42%
Opening 15:42 05/15 EDT
OPEN
0.0423
PREV CLOSE
0.0423
HIGH
0.0432
LOW
0.0390
VOLUME
198.39K
TURNOVER
--
52 WEEK HIGH
0.0800
52 WEEK LOW
0.0253
MARKET CAP
--
P/E (TTM)
-0.0053
1D
5D
1M
3M
1Y
5Y
1D
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga · 1d ago
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga · 2d ago
Tevogen Bio Holdings Inc trading halted, volatility trading pause
TipRanks · 3d ago
Tevogen Bio Holdings Inc trading resumes
TipRanks · 3d ago
Tevogen Enters $3M Private Placement PIPE Financing At $8.00/Prefunded Warrant, Issuing 375K Warrants Each Exercisable For The Purchase Of 1 Share Of The Company's Common Stock
Benzinga · 3d ago
TEVOGEN BIO HOLDINGS INC - ANNOUNCES $3 MLN PIPE FINANCING WITH THE PATEL FAMILY, LLP
Reuters · 3d ago
Press Release: Tevogen Announces $3 Million Private Investment at $8 Per Share, a 14% Premium from Latest Market Close
Dow Jones · 3d ago
Weekly Report: what happened at TVGN last week (0504-0508)?
Weekly Report · 4d ago
More
About TVGNW
Tevogen Bio Holdings Inc. is a clinical-stage specialty immunotherapy company. The Company is harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs), to develop off-the-shelf, genetically unmodified precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders, aiming to address the unmet needs of patient populations. Its first product candidate, TVGN 489, is an off-the-shelf, allogeneic cytotoxic CD8+ T cell therapy designed to fill a critical gap in COVID-19 therapeutic solutions for the immunocompromised and the high-risk elderly, with potential applications in both treatment and prevention of Long COVID. In addition to TVGN 489, it has several product candidates under early-stage development. The Company is developing Epstein-Barr virus (EBV) specific CTLs for potential use in multiple sclerosis (MS) and EBV-associated lymphomas. Its TVGN 601 is being developed for MS, and its TVGN 930 is being developed for EBV-associated lymphomas.

Webull offers Tevogen Bio Holdings Inc stock information, including NASDAQ: TVGNW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TVGNW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TVGNW stock methods without spending real money on the virtual paper trading platform.